Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
出版年份 2012 全文链接
标题
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
作者
关键词
-
出版物
PLoS One
Volume 7, Issue 3, Pages e33797
出版商
Public Library of Science (PLoS)
发表日期
2012-03-31
DOI
10.1371/journal.pone.0033797
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis
- (2011) R. A. Linker et al. BRAIN
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages duringchronic hepatitis C virus infection
- (2010) Cheng J. Ma et al. IMMUNOLOGY
- Interleukin-27 Induces a STAT1/3- and NF-κB-dependent Proinflammatory Cytokine Profile in Human Monocytes
- (2010) Christina Guzzo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- Updates on the Treatment of Lupus Nephritis
- (2010) A. S. Bomback et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
- (2010) G. Comi et al. Multiple Sclerosis Journal
- The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
- (2009) Howard L. Weiner ANNALS OF NEUROLOGY
- Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system
- (2009) Ulf Schulze-Topphoff et al. NATURE MEDICINE
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
- (2009) Per Björk et al. PLOS BIOLOGY
- Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System
- (2008) Marco Prinz et al. IMMUNITY
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
- The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
- (2008) Beichu Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Tempering antigen-presenting cells in multiple sclerosis
- (2008) Thomas Prod'homme et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started